These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34896383)

  • 1. [Digital therapeutics: Which barriers for market access?].
    Rochereau A; Dorphin C; Martelli N
    Ann Pharm Fr; 2022 Jul; 80(4):519-530. PubMed ID: 34896383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to Creating Scalable Business Models for Digital Health Innovation in Public Systems: Qualitative Case Study.
    Kelley LT; Fujioka J; Liang K; Cooper M; Jamieson T; Desveaux L
    JMIR Public Health Surveill; 2020 Dec; 6(4):e20579. PubMed ID: 33300882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Status and Future Direction for Digital Therapeutics in Children and Adolescent Psychiatry.
    Choi H; Kim B; Kim I; Kang JG; Lee Y; Lee H; Park MH
    Soa Chongsonyon Chongsin Uihak; 2023 Oct; 34(4):192-203. PubMed ID: 37841489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics.
    Kim SY; Moon JY; Shin J; Sim JY; Kim M; Jang J
    Yonsei Med J; 2022 Jan; 63(Suppl):S56-S62. PubMed ID: 35040606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Dervaux B; Baseilhac E; Fagon JY; ; Ameye V; Angot P; Audry A; Becquemont L; Borel T; Cazeneuve B; Courtois J; Detournay B; Favre P; Granger M; Josseran A; Lassale C; Louvet O; Pinson J; de Pouvourville G; Rochaix L; Rumeau-Pichon C; de Saab R; Schwarzinger M; Sun A
    Therapie; 2013; 68(4):253-7. PubMed ID: 27392727
    [No Abstract]   [Full Text] [Related]  

  • 8. The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks.
    Yan K; Balijepalli C; Druyts E
    Front Digit Health; 2021; 3():667016. PubMed ID: 34713140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies Of Prescription Digital Therapeutics Often Lack Rigor And Inclusivity.
    Kumar A; Ross JS; Patel NA; Rathi V; Redberg RF; Dhruva SS
    Health Aff (Millwood); 2023 Nov; 42(11):1559-1567. PubMed ID: 37931187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke.
    Choi MJ; Kim H; Nah HW; Kang DW
    J Stroke; 2019 Sep; 21(3):242-258. PubMed ID: 31587534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building and changing business models: a qualitative study among Dutch physiotherapy primary healthcare organisations.
    IJntema R; Barten DJ; Duits H; Tjemkes B; Veenhof C
    Prim Health Care Res Dev; 2022 Mar; 23():e19. PubMed ID: 35314018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What value do digital health solutions bring, what are the funding mechanisms and evaluations?
    Charle-Maachi C; Moreau-Gaudry A; Sainati D; Camus D; Adenot I; Barthelemy CE; de Chalus T; Debroucker F; Denis F; Gourio C; Habran E; Kamal N; Le Douarin YM; Rosier A; Schuck S; Thébaut JF; Trancart A; Vercamer V
    Therapie; 2022; 77(1):133-147. PubMed ID: 35034780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of economic, educational and social resources in supporting the use of digital health technologies by people with T2D: a qualitative study.
    Turnbull S; Lucas PJ; Hay AD; Cabral C
    BMC Public Health; 2021 Feb; 21(1):293. PubMed ID: 33546661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Readiness for Delivering Digital Health at Scale: Lessons From a Longitudinal Qualitative Evaluation of a National Digital Health Innovation Program in the United Kingdom.
    Lennon MR; Bouamrane MM; Devlin AM; O'Connor S; O'Donnell C; Chetty U; Agbakoba R; Bikker A; Grieve E; Finch T; Watson N; Wyke S; Mair FS
    J Med Internet Res; 2017 Feb; 19(2):e42. PubMed ID: 28209558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital therapeutics from bench to bedside.
    Wang C; Lee C; Shin H
    NPJ Digit Med; 2023 Mar; 6(1):38. PubMed ID: 36899073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of digital therapeutics and the changing future of healthcare.
    Dang A; Arora D; Rane P
    J Family Med Prim Care; 2020 May; 9(5):2207-2213. PubMed ID: 32754475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology.
    Ribba B; Peck R; Hutchinson L; Bousnina I; Motti D
    Clin Pharmacol Ther; 2023 Sep; 114(3):578-590. PubMed ID: 37392464
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.